Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
3
×
biotech
boston
boston blog main
boston top stories
life sciences
national blog main
san francisco blog main
abbvie
allergan
alzheimer's disease
azacitidine
beta-thalassemia
biopharmaceutical
business
clinical trials
crispr
cynthia collins
dacogen
decitabine
dna
editas medicine
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
gene editing
google
health
insulated genomic domains
kaleido biosciences
leber congenital amaurosis type 10
mahesh karande
michelle robertson
national top stories
new york blog main
new york top stories
omega therapeutics
panobinostat
What
biotech
3
×
medicines
3
×
research
3
×
abbvie
new
abbott
agreement
aims
alliance
announced
approach
backed
based
biopharma
calico
called
center
companies
company
countries
debuts
developing
drugs
editas
editing
employes
epigenetic
epigenetics
exits
experimental
facility
field
firm
flagship’s
formed
gene
genetic
google
health
invest
Language
unset
Current search:
deals
×
medicines
×
biotech
×
research
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@venturebeat.com
9 years ago
Google-backed Calico and Abbott Labs spinoff will set up $1.5B research center